Stake Announced
Hansoh Pharmaceutical Group Co. stake in Avere Therapeutics
Announced 21 Jul 2026
Advisers
Avere Therapeutics
Target
Not disclosed
Hansoh Pharmaceutical Group Co.
Acquirer
- Legal adviser
- Target
- Avere Therapeutics
- Acquirer
- Hansoh Pharmaceutical Group Co.
- Target based in
- United States
- Buyer based in
- China
- Structure
- Minority stake
- Sector
- Biotech
- Tags
- Biotech, Pharma, Drug Development
In the league tables
Similar deals
- Adial Pharmaceuticals acquisition of Azora Therapeutics Jun 2026 · Biotech
- Amneal Pharmaceuticals acquisition of Kashiv BioSciences Apr 2026 · US$375m · Biotech
- Eli Lilly and Company acquisition of Ventyx Biosciences Jan 2026 · US$1.2bn · Biotech
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
